Recipients of 2015 Ferring Innovation Grants announced

NewsGuard 100/100 Score

Ferring Research Institute Inc. today announced the recipients of the 2015 Ferring Innovation Grants. This global program awards each recipient $50,000 to support research in the fields of Reproductive Health, Gastroenterology and/or Urology. This year's winners are:

  • Steven Cohn, M.D., Ph.D., University of Virginia, School of Medicine: Immunomodulation of RELMβ as a treatment for IBD
  • Nardhy Gomez-Lopez, Ph.D., Wayne State University, School of Medicine: A role for exendin-4 in the prevention of preterm birth
  • Peter Gray, Ph.D., The Salk Institute for Biological Studies: Targeting Cripto in castration-resistant prostate cancer
  • Guiying Nie, Ph.D., Hudson Institute of Medical Research: Improving fertility by targeting a novel uterine barrier for embryo implantation
  • Laura Parry, Ph.D., The University of Melbourne: Treatment of vascular dysfunction in preeclampsia

"We are delighted with the response to the 2015 Ferring Innovation Grant initiative and look forward to the outcome of the innovative research being carried out by all of this year's grant awardees" said Keith James, President Ferring Research Institute, Senior Vice President Research & Development.

Source:

Ferring Reserach Institute

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer